These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28689532)

  • 1. Hepatitis C Virus Infection with Multiple Genotypes.
    Ghani E; Noor M; Khalid S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):380-381. PubMed ID: 28689532
    [No Abstract]   [Full Text] [Related]  

  • 2. Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.
    Trippoli S; Fadda V; Maratea D; Messori A
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):983-4. PubMed ID: 26114910
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus.
    Zeuzem S; Rüster B; Roth WK
    Z Gastroenterol; 1994 Jun; 32(6):342-7. PubMed ID: 7526563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pediatrician and hepatitis C virus].
    Bost-Bru C
    Arch Pediatr; 1999 Oct; 6(10):1122-5. PubMed ID: 10544791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
    Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL;
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of hepatitis C virus RNA].
    Ohishi W; Chayama K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):214-8. PubMed ID: 15359795
    [No Abstract]   [Full Text] [Related]  

  • 9. PSG consensus statement on management of hepatitis C virus infection--2003.
    Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
    J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
    [No Abstract]   [Full Text] [Related]  

  • 10. Retreatment of a treatment-experienced patient with genotype 6 hepatitis C virus infection: follow-up on a reported case.
    Spooner LM; Abraham GM
    Am J Health Syst Pharm; 2015 Jan; 72(1):14-6. PubMed ID: 25511831
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
    Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
    [No Abstract]   [Full Text] [Related]  

  • 12. [Argentine consensus on hepatitis C 2013].
    Reggiardo MV; Tanno F; Mendizabal M; Galdame O
    Acta Gastroenterol Latinoam; 2014 Jun; 44(2):154-73. PubMed ID: 25199310
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
    Sharvadze LG; Gogichaishvili ShSh; Sakandelidze TsG; Zhamutashvili MT; Chkhartishvili NI
    Georgian Med News; 2009 Jan; (166):61-4. PubMed ID: 19202222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection: Are there still specific problems with genotype 3?
    Gondeau C; Pageaux GP; Larrey D
    World J Gastroenterol; 2015 Nov; 21(42):12101-13. PubMed ID: 26576095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection.
    Knops E; Heger E; Koenig C; Moebius U; Lübke N; Kaiser R; Di Cristanziano V; Hüsgen L; Kocyigit C; Rupp J; Sierra S
    Clin Microbiol Infect; 2018 Apr; 24(4):440-441. PubMed ID: 29104172
    [No Abstract]   [Full Text] [Related]  

  • 16. The results of Phase III clinical trials with telaprevir and boceprevir presented at the Liver Meeting 2010: a new standard of care for hepatitis C virus genotype 1 infection, but with issues still pending.
    Pawlotsky JM
    Gastroenterology; 2011 Mar; 140(3):746-54. PubMed ID: 21255572
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of new hepatitis C treatments in different regions of the world.
    Wei L; Lok AS
    Gastroenterology; 2014 May; 146(5):1145-50.e1-4. PubMed ID: 24662488
    [No Abstract]   [Full Text] [Related]  

  • 18. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of direct sequencing and Invader assay for Y93H mutation and response to interferon-free therapy in hepatitis C virus genotype 1b.
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Kawashima H; Ishikawa T; Tachi Y; Hattori M; Katano Y; Goto H; Hirooka Y
    J Gastroenterol Hepatol; 2018 Jan; 33(1):249-255. PubMed ID: 28440885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.